Cytespace

What Cytespace does

Cytespace is a Clinical Research Organization (CRO) headquartered in Bangalore, India, founded in 2011 and acquired by global CRO Premier Research in April 2021, under which it continues to operate as a Site Services Organization (SSO) under its own brand. The company delivers three core service lines — Site Solutions (site management, patient recruitment, feasibility, regulatory solutions, quality management, and trial conduct across 200+ hospital partnerships in Asia and Africa), Biometric Solutions (end-to-end clinical data management, biostatistics, statistical programming, medical writing, strategic consulting, CDISC standards implementation, and data science), and FSP Solutions (customizable functional outsourcing for pharma and CROs). Its technology stack centers on Cytestream, an in-house 21 CFR Part 11 compliant cloud-based trial management platform, and Nukleus, an FDA-compliant EDC platform co-developed with nuvoteQ for emerging markets, supplemented by deep experience across Medidata Rave, InForm, Clindex, and other EDC platforms (1,800,000+ cumulative hours).

The company serves biotech and specialty pharma sponsors, global pharmaceutical companies, CROs, and investigators — primarily through a direct enterprise sales motion targeting companies conducting clinical studies in India and other emerging markets. Cytespace monetizes via managed services and professional services engagements (quote-based, not publicly disclosed pricing) with reported execution metrics of eCRF design in 6–8 weeks (vs. industry 12–14 weeks) and database lock within 21 days from LPV. The leadership team is anchored by Dr. Ferzaan Engineer (Co-founder and Chairman; former Quintiles India Chairman and CEO 1997–2010) and includes several other Quintiles alumni, giving Cytespace a pedigree from the founding generation of India's CRO industry. Following the Premier Research acquisition, the company operates as part of a larger global CRO while maintaining operational independence as the India site services brand.

Name

Cytespace

Legal name

Cytespace Research Private Limited

Website

https://cytespace.com

Company type

Private

Founded year

2011

Operating status

Acquired

Headcount range

101–250 employees

Short description

Cytespace is an India-headquartered CRO providing site management, biometrics, and FSP solutions to biotech, specialty pharma, global pharma, and CROs across 200+ hospital partnerships in Asia and Africa, now operating as a Site Services Organization under Premier Research.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical trial services
• Site management solutions
• Biometrics CRO services
• Functional service provider
• Electronic data capture

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices20 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Site Management Solutions: Clinical trial site management services including patient recruitment and retention, feasibility studies, site start-up, regulatory solutions, quality management, and trial management. Delivered through a network of 200+ hospital partnerships across Asia and Africa.
2. End-to-End Biometrics Solutions: Comprehensive EDC services including clinical data management, biostatistics, statistical programming, medical writing, and standards implementation. Services are source-verified, logical, reproducible, and cost-efficient.
3. Functional Services Provider (FSP): Customizable FSP solutions for pharma and CROs including data management, medical coding, database programming, records management, study start-up, biostatistics, centralized monitoring, safety, medical writing, regulatory affairs, and back-end activities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Cytespace is a Clinical Research Organization (CRO) delivering Site Management Solutions (patient recruitment, feasibility, site start-up, regulatory, quality and trial management across 200+ hospital partnerships), End-to-End Biometric Solutions (EDC-enabled clinical data management, biostatistics, statistical programming, medical writing, strategic consulting, standards implementation, and data science), and Functional Services Provider (FSP) solutions for pharma and CRO customers. Services are delivered through Asia and Africa on-site networks supported by proprietary Cytestream trial management software and partner-built Nukleus EDC.

Product overview

Cytespace is a Clinical Research Organization (CRO) that operates as a platform-plus-modules architecture offering three core service lines: Site Solutions, Biometric Solutions, and FSP (Functional Services Provider) Solutions. Site Solutions provides site management with patient recruitment across 200+ hospital partnerships. Biometric Solutions encompasses Clinical Data Management, Biostatistics, Statistical Programming, Medical Writing, Strategic Consulting, Standards Implementation, and Data Science modules. FSP Solutions delivers customizable functional services for pharma and CROs. Supporting technology includes Cytestream (in-house 21 CFR Part 11 compliant trial management platform) and Nukleus (EDC platform partnered with nuvoteQ). The company was acquired by Premier Research in April 2021 and continues operating under the Cytespace brand.

Differentiator

Problem solved

Functional benefit

Products and services

• Site Solutions Scalable site management solution delivering better efficiency, quality and patient recruitment to global pharma customers, CROs and investigators via a network of 200+ hospital partnerships across Asia and Africa; spans patient recruitment and retention, feasibility studies, site start-up, regulatory submissions, quality management and trial management.
• Biometric Solutions End-to-end EDC-enabled biometrics services for Phase I/II through large Phase III–IV multinational studies, covering Clinical Data Management, Biostatistics, Statistical Programming, Medical Writing, Strategic Consulting, Standards Implementation (CDISC), and Data Science with source-verified, logical, reproducible, cost-efficient outputs.
• FSP Solutions Functional Services Provider solutions delivered under a 'Collaborship Model' for pharma and CROs expanding clinical research business in India and other geographies; covers Data Management, Medical Coding, Database Programming and Validation, Records Management, Study Start-up, Biostatistics, Statistical Programming, Centralized Monitoring, Safety and Medical Writing, Regulatory Affairs, and Learning and Development.
• Cytestream In-house 21 CFR Part 11 compliant cloud-based software that manages all aspects of trial operations from planning and study start-up through to close-out; provides patient database management, document sharing, reporting, and financial tracking and is aimed at independent study sites and networks.
• Nukleus EDC Web-based FDA-compliant Electronic Data Capture (EDC) platform built for emerging markets using first-world technologies, accessible from any device; developed jointly by Cytespace as technology enabler and nuvoteQ.

Quantifiable outcome

• eCRF design and programming completed in 6-8 weeks for large complex Phase III studies (vs industry standard 12-14 weeks)
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• MedDRA MSSOcoreStrategic or Co-development Partner · 22 January 2020Cytespace Research Pvt. Ltd. hosted the face-to-face MedDRA training programme conducted by MedDRA MSSO at Bangalore, India. The one-day classroom training programme was held on 22nd and 23rd, Jan 2020 at WeWork in Ashok Nagar, Bengaluru.
• nuvoteQcoreTechnology or IntegrationCytespace is the technology enabler for nuvoteQ's Nukleus EDC platform. Cytespace has been an active partner in developing and moulding this FDA Compliant Electronic Data Capture system into its current shape. Nukleus is built for emerging markets using first-world technologies.

Scale indicators15 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Syneos Health: Global biopharmaceutical services organization with clinical development and FSP capabilities and a meaningful India footprint; overlapping customer base (biotech/specialty pharma) and overlapping service portfolio (clinical operations, biometrics, FSP) make it a relevant CRO peer.
• Parexel International: Top-five global CRO with established India operations spanning clinical operations, biostatistics, and FSP; competes head-to-head with Cytespace for biotech/specialty pharma site management and biometrics outsourcing in India and Asia.
• ICON plc: Global CRO with significant India presence delivering clinical operations, biometrics, and FSP services; directly competes with Cytespace for sponsor site management and data management work in emerging markets.
• IQVIA: Largest global CRO (and direct successor to Quintiles, where multiple Cytespace founders trained); operates the deepest India footprint among global CROs and competes for the same biotech and specialty pharma site-management, biometrics, and FSP engagements.
• Premier Research: Global CRO that acquired Cytespace in April 2021; provides the parent context in which Cytespace's site network, biometrics, and FSP services are now positioned within end-to-end clinical development offerings to biotech and specialty pharma sponsors.
• Labcorp Drug Development (formerly Covance): Major global CRO with central laboratory, clinical development, and FSP capabilities; has a sizable India footprint and competes with Cytespace for site management, biometrics, and FSP work from global sponsors.
• Medpace Holdings: Mid-to-large global CRO with full-service clinical development and biometrics; competes with Cytespace (and its Premier Research parent) for biotech/specialty pharma outsourcing contracts, including those involving emerging-market sites.

Regional players

• Syngene International: Indian CRO/CDMO with strong clinical development services arm under Biocon; competes regionally for site management, biometrics, and FSP work sourced from global pharma and biotech sponsors with India requirements.

Direct peers

• Lambda Therapeutic Research: India-headquartered full-service CRO providing clinical trials, biometrics, bioanalysis, and site management services; one of the closest direct competitors to Cytespace in the Indian site-management and biometrics market.
• Veeda Clinical Research: India-based CRO offering clinical research, bioequivalence, biopharma, and clinical trial support; competes with Cytespace for India-based clinical conduct, especially bioequivalence and early-phase work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cytespace